InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Tarr Mark J, Chairman & CEO. Insider active across 2 companies, notably Encompass Health Corp. Cumulatively, 28 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €20.3m. History available since 3 January 2022. The latest transaction was filed on 10 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Tarr Mark J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
171,569 shares@ US$125.46Encompass Health Common StockSEC:0000785161-26-000191:0
1,579 shares@ US$126.06Encompass Health Common StockSEC:0000785161-26-000191:1
2,187 shares@ US$107.881.2% of flowEncompass Health Common StockSEC:0000785161-26-000087:0
2,488 shares@ US$106.151.4% of flowEncompass Health Common StockSEC:0000785161-26-000077:0
43,378 shares@ US$107.1524.3% of flowEncompass Health Common StockSEC:0000785161-26-000061:0
100,946 shares0Encompass Health Common StockSEC:0000785161-26-000039:0
16,216 shares@ US$108.039.1% of flowEncompass Health Common StockSEC:0000785161-26-000032:0
56,306 shares@ US$35.0615.8% of flowEncompass Health Common StockSEC:0001127602-25-015049:0
2,187 shares@ US$100.141.9% of flowEncompass Health Common StockSEC:0001127602-25-007397:0
2,488 shares@ US$97.532.1% of flowEncompass Health Common StockSEC:0001127602-25-006832:0
12,152 shares0Encompass Health Common StockSEC:0001127602-25-006188:0
31,609 shares@ US$92.3525.4% of flowEncompass Health Common StockSEC:0001127602-25-000294:0
19,460 shares@ US$35.835.9% of flowEncompass Health Common StockSEC:0001127602-24-013718:0
74,711 shares0Encompass Health Common StockSEC:0001127602-24-007557:0
2,487 shares@ US$75.251.6% of flowEncompass Health Common StockSEC:0001127602-24-006853:0
25,159 shares@ US$66.7213.7% of flowEncompass Health Common StockSEC:0001127602-24-000348:0
25,330 shares@ US$26.555.6% of flowEncompass Health Common StockSEC:0001127602-23-022891:0
2,256 shares@ US$60.221.2% of flowEncompass Health Common StockSEC:0001127602-23-007406:0
61,503 shares0Encompass Health Common StockSEC:0001127602-23-006976:0
2,100 shares@ US$62.861.1% of flowEncompass Health Common StockSEC:0001127602-23-006548:0
14,576 shares@ US$59.817.4% of flowEncompass Health Common StockSEC:0001127602-23-000479:0
20,449 shares@ US$20.073.6% of flowEncompass Health Common StockSEC:0001127602-22-021346:0
1,873 shares@ US$65.520.7% of flowEncompass Health Common StockSEC:0001127602-22-006970:0
3,782 shares@ US$65.911.4% of flowEncompass Health Common StockSEC:0001127602-22-006355:0
11,327 shares@ US$65.264.0% of flowEncompass Health Common StockSEC:0001127602-22-000857:0
25 of 28 declarations
About Tarr Mark J
Tarr Mark J is President & CEO. He has 26 filings in total. In the recent filings observed from 2016-01-06 to 2026-03-03, the reported sell volume is EUR 1473399, the modal transaction nature is tax withholding, and the top filings concern Encompass Health Corp.
